-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Cytek Biosciences, Inc. quarterly and annual Revenues history and change rate from Q2 2020 to Q3 2024.
- Cytek Biosciences, Inc. Revenues for the quarter ending 30 Sep 2024 was $51,500,000, a 7.3% increase year-over-year.
- Cytek Biosciences, Inc. Revenues for the twelve months ending 30 Sep 2024 was $201,211,000, a 813% increase year-over-year.
- Cytek Biosciences, Inc. annual Revenues for 2023 was $193,015,000, a 6414% increase from 2022.
- Cytek Biosciences, Inc. annual Revenues for 2022 was $2,963,000, a 36% increase from 2021.
- Cytek Biosciences, Inc. annual Revenues for 2021 was $2,181,000, a 207% increase from 2020.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)
Revenues, YoY Annual Change (%)